US gives green light to Guidant's chromium stent
This article was originally published in Clinica
Executive Summary
The FDA has approved Guidant's cobalt chromium coronary stent for sale in the US. The PMA for the Multi-link Vision system signals something of a regulatory rehabilitation for the device, which was recalled from release in Europe and Australia in April following a technical problem with the delivery system.